Dominique Tytgat

Addressing potential prior‐data conflict when using informative priors in proof‐of‐concept studies

Rosalind Walley, Timothy Mutsvari, Dominique Tytgat, 2016, Pharmaceutical statistics.

Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action

Richard E Carson, Nabeel Nabulsi, Daniel Holden, 2016, Epilepsia.

Addressing potential prior‐data conflict when using informative priors in proof‐of‐concept studies

Rosalind Walley, Timothy Mutsvari, Dominique Tytgat, 2017, Pharmaceutical statistics.

Physiologically based pharmacokinetics (PBPK)

Dominique Tytgat, Italo Poggesi, J. Watelet, 2009, Drug metabolism reviews.